A spokesman for Chinese biopharmaceutical accompany Sinovac Biotech (Sinovac) confirmed on 3 March 2021 that the company's annual production capacity of COVID-19 vaccine can reach two billion doses by June 2021, Reuters news agency reported on Wednesday.

Reportedly, this figure is double Sinovac's prior yearly capacity of one billion doses in the form of bulk ingredient, which the firm had said it could reach by February 2021.

Reuters added that the Global Times, an English-language daily tabloid newspaper under China's state media People's Daily newspaper, had first reported this news, citing a comment from Sinovac's chief executive.